136 related articles for article (PubMed ID: 25310895)
1. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.
Zhou Q; Dai J; Chen T; Dada LA; Zhang X; Zhang W; DeCamp MM; Winn RA; Sznajder JI; Zhou G
Cell Signal; 2017 Oct; 38():49-59. PubMed ID: 28652146
[TBL] [Abstract][Full Text] [Related]
3. Common cytotoxic chemotherapeutics induce epithelial-mesenchymal transition (EMT) downstream of ER stress.
Shah PP; Dupre TV; Siskind LJ; Beverly LJ
Oncotarget; 2017 Apr; 8(14):22625-22639. PubMed ID: 28186986
[TBL] [Abstract][Full Text] [Related]
4. SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer.
Liu L; Zhang J; Yang X; Fang C; Xu H; Xi X
PLoS One; 2015; 10(9):e0138515. PubMed ID: 26407074
[TBL] [Abstract][Full Text] [Related]
5. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.
Liu JH; Yang HL; Deng ST; Hu Z; Chen WF; Yan WW; Hou RT; Li YH; Xian RT; Xie YY; Su Y; Wu LY; Xu P; Zhu ZB; Liu X; Deng YL; Wang YB; Liu Z; Fang WY
Acta Pharmacol Sin; 2022 Oct; 43(10):2687-2695. PubMed ID: 35296779
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel Inhibits Epithelial-Mesenchymal Transition in Human Mammary Cells.
Beerkens SJ; King JJ; Irving KL; Bhatia S; Thompson EW; Smith NM; Iyer KS; Evans CW
Mol Pharm; 2024 Jan; 21(1):53-61. PubMed ID: 38029291
[TBL] [Abstract][Full Text] [Related]
7. Chronic inorganic arsenic exposure in vitro induces a cancer cell phenotype in human peripheral lung epithelial cells.
Person RJ; Ngalame NN; Makia NL; Bell MW; Waalkes MP; Tokar EJ
Toxicol Appl Pharmacol; 2015 Jul; 286(1):36-43. PubMed ID: 25804888
[TBL] [Abstract][Full Text] [Related]
8. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.
Gu J; Zhang J; Xia R; Wang X; Yang J; Xie F; Zhou Q; Li J; Zhang T; Chen Q; Fan Y; Guo S; Wang H
Drug Resist Updat; 2024 Mar; 73():101027. PubMed ID: 38290407
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells.
Zhang Y; Huang S
Biol Chem; 2015 Aug; ():. PubMed ID: 26351908
[TBL] [Abstract][Full Text] [Related]
10. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.
Ma J; Zeng F; Ma C; Pang H; Fang B; Lian C; Yin B; Zhang X; Wang Z; Xia J
Am J Cancer Res; 2016; 6(6):1384-95. PubMed ID: 27429851
[TBL] [Abstract][Full Text] [Related]
11. Target c-Myc to treat pancreatic cancer.
Ala M
Cancer Biol Ther; 2022 Dec; 23(1):34-50. PubMed ID: 34978469
[TBL] [Abstract][Full Text] [Related]
12. Repression of LKB1 by
Izreig S; Gariepy A; Kaymak I; Bridges HR; Donayo AO; Bridon G; DeCamp LM; Kitchen-Goosen SM; Avizonis D; Sheldon RD; Laister RC; Minden MD; Johnson NA; Duchaine TF; Rudoltz MS; Yoo S; Pollak MN; Williams KS; Jones RG
Cell Rep Med; 2020 May; 1(2):100014. PubMed ID: 32478334
[TBL] [Abstract][Full Text] [Related]
13. The impact of vascular division sequence and epithelial-mesenchymal transition status on postoperative recurrence in lung adenocarcinoma.
Nishikawa S; Menju T; Takahashi K; Sowa T; Yoshizawa A; Date H
Asian Cardiovasc Thorac Ann; 2024 Mar; 32(2-3):123-132. PubMed ID: 38254290
[TBL] [Abstract][Full Text] [Related]
14. Identification and comprehensive analysis of super-enhancer related genes involved in epithelial-to-mesenchymal transition in lung adenocarcinoma.
Liu Y
PLoS One; 2023; 18(9):e0291088. PubMed ID: 37669296
[TBL] [Abstract][Full Text] [Related]
15. Hsa-miR-335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine-1.
Wang Y; Zhang J; Zhong LY; Huang SJ; Yu NN; Ouyang L; Niu YL; Chen JX; Lu CH; He QY
MedComm (2020); 2021 Dec; 2(4):810-820. PubMed ID: 34977878
[TBL] [Abstract][Full Text] [Related]
16. RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M; Rodríguez-Acebes S; Blondeau J; Parent MA; Zocco M; Song Y; de Maertelaer V; Moers V; Latil M; Dubois C; Coulonval K; Impens F; Van Haver D; Dufour S; Uemura A; Sotiropoulou PA; Méndez J; Blanpain C
Nature; 2023 Apr; 616(7955):168-175. PubMed ID: 36949199
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus Induces Epithelial-Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b.
Mukhopadhyay U; Banerjee A; Chawla-Sarkar M; Mukherjee A
Front Microbiol; 2021; 12():631183. PubMed ID: 33679655
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular characterization of novel pulmonary adenocarcinoma cell lines established from a dog.
Kobayashi K; Takemura RD; Miyamae J; Mitsui I; Murakami K; Kutara K; Saeki K; Kanda T; Okamura Y; Sugiyama A
Sci Rep; 2023 Oct; 13(1):16823. PubMed ID: 37798461
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-mediated EMT and CSCs in cancer chemoresistance.
Dong B; Li S; Zhu S; Yi M; Luo S; Wu K
Exp Hematol Oncol; 2021 Feb; 10(1):12. PubMed ID: 33579377
[TBL] [Abstract][Full Text] [Related]
20. Role of c-Myc in lung cancer: Progress, challenges, and prospects.
Wallbillich NJ; Lu H
Chin Med J Pulm Crit Care Med; 2023 Sep; 1(3):129-138. PubMed ID: 37920609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
